60 results
8-K
EX-99.1
NERV
Minerva Neurosciences Inc
27 Feb 24
Other Events
8:04am
meaningful change, and to demonstrate the long-term safety of the proposed dose.
In addition to the clinical deficiencies described above, the FDA also
8-K
EX-99.1
slcxrb8art
22 Aug 22
Minerva Neurosciences Submits New Drug Application to FDA for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia
8:16am
8-K
EX-99.1
hk7vqpexcqeipo48p 5f
5 Jan 22
Regulation FD Disclosure
8:15am
SC TO-I/A
EX-99
2p1sr5dk 550
2 Aug 21
Issuer tender offer statement (amended)
9:14am
SC TO-I
EX-99
tlgoue3dhjwbh6o2ewf
6 Jul 21
Issuer tender offer statement
4:13pm